A cystic fibrosis cure for all? Gene editing shows promise
There's been advancement on cystic fibrosis, but there are still those living with the disease who get no relief from current treatments. Gene editing may help.
www.nhlbi.nih.govI don’t have live tool access right now to pull the very latest headlines, but I can summarize the current landscape on CFTR news and point you to where to look.
What CFTR is about: CFTR is the gene encoding the CFTR protein, whose dysfunction causes cystic fibrosis. Recent coverage often centers on new modulators, clinical trial results, and approaches like gene editing or molecular prosthetics that aim to restore CFTR function .
Latest broad themes you’ll see in news:
How to get the latest news now:
Illustrative example:
Would you like me to search for the very latest CFTR news and provide a concise, cited summary with links? If you have a preferred region (e.g., US, Europe) or a mutation subset, tell me and I’ll tailor the update.
There's been advancement on cystic fibrosis, but there are still those living with the disease who get no relief from current treatments. Gene editing may help.
www.nhlbi.nih.govProfessor Tzyh-Chang Hwang Deciphers Pathogenic Protein Structure, Advancing Drug Development for Cystic Fibrosis and Diarrheal Diseases
www.nycu.edu.twLARVOL VERI predictive biomarker news, CFTR (CF Transmembrane Conductance Regulator)
veri.larvol.comHow are a football match, a plug socket and a birthday cake linked to CFTR, the gene that causes cystic fibrosis? Find out by reading our ‘Research blast’ article celebrating 30 years since the gene was discovered.
www.cysticfibrosis.org.ukCystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
www.uab.edua collaboration with the CF Foundation (CFF). This CF research program would work to find medications, called modulators, to correct defective CFTR protein. Since the start of this collaboration, Vertex has developed Kalydeko® (ivacaftor), Orkambi® (lumacaftor/ivacaftor) and … paved the way for other CFTR modulators that may benefit many more patients. In 2015, lumacaftor/ivacaftor (Orkambi) combination therapy was approved by the FDA for patients with two F508del mutations (the most common CF...
www.med.umich.eduA Potential Breakthrough Treatment for Cystic Fibrosis Enters Clinical Trial Led by CI MED and U of Iowa Researchers
medicine.illinois.eduA new study confirms ivacaftor's impact on inflammation in people with cystic fibrosis (CF). Ivacaftor targets the defective protein that causes CF.
news.cuanschutz.eduCLEVELAND - Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 New England Journal of Medicine, find that the oral medicatio...
case.edu